Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$14.75 USD
-1.21 (-7.58%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $14.77 +0.02 (0.14%) 7:58 PM ET
1-Strong Buy of 5 1
B Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.65 | 0.00% |
Earnings Summary
For their last quarter, Entrada Therapeutics (TRDA) reported earnings of $0.68 per share, beating the Zacks Consensus Estimate of $-0.38 per share. This reflects a positive earnings surprise of 278.95%. Look out for TRDA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.65 per share, reflecting a year-over-year increase of 183.33%.
Earnings History
Price & Consensus
Zacks News for TRDA
Perrigo (PRGO) Beats on Q2 Earnings, Lags Sales, Cuts View
TRDA: What are Zacks experts saying now?
Zacks Private Portfolio Services